v3.26.1
Consolidated income statement - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Consolidated income statement      
Revenue € 788,373 € 796,967 € 781,426
Cost of Revenue (674,152) (682,086) (606,375)
Gross profit 114,221 114,881 175,051
Operating income (expenses)      
Research and development (37,509) (50,857) (68,529)
Selling, general and administrative expenses (175,970) (188,201) (169,610)
Other operating income 65,599 52,700 64,793
Other operating expenses (21,924) (16,116) (44,202)
Impairments of intangible assets     (5,011)
Reorganization costs (633) (54,930) 0
Total operating income (expenses) (170,438) (257,403) (222,558)
Operating income (loss) (56,217) (142,522) (47,507)
Non-operating income (expense)      
Gain (loss) on investment in financial instruments revaluation (677) (38,513) (9,143)
Share of profit (loss) and revaluation of at-equity investments (1,085) (4,312) (20,752)
Other financial income 4,424 2,435 9,263
Other financial expense (14,442) (11,699) (11,739)
Other non-operating income (expense) (18,769) 636 (714)
Net Income (loss) before taxes (86,766) (193,977) (80,593)
Income taxes (16,751) (2,102) (3,320)
Net income (loss) € (103,517) € (196,078) € (83,913)
Weighted average shares outstanding 177,578,262 177,295,234 176,916,663
Net income per share (basic) € (0.58) € (1.11) € (0.47)
Net income per share (diluted) € (0.58) € (1.11) € (0.47)